Skip Navigation

University at Buffalo - The State University of New York
  1. About
    1. Contact Us
    2. News, Alerts and Tips
  2. EH&S Programs
    1. Accident Reporting
    2. Asbestos and Lead
    3. Battery Recycling
    4. Biological Safety
    5. Chemical Safety
    6. Construction Safety
    7. Environmental Protection
    8. Fire and Life Safety
    9. General Safety
    10. Hazardous Waste
    11. Industrial Hygiene
    12. Laboratory Safety
    13. Public Health
    14. Radiation Safety
    15. EH&S Projects
    16. Small Claims
  3. Policies
    1. Building Evacuation Plans
    2. Campus Commitment to Safety
    3. Corridor Use Policy
    4. Excavation Marking and Dig Safely Procedure
    5. Guidelines for Drain Disposal of Lab Waste
    6. Lab Facilities & Equipment Servicing Release
    7. Outdoor Projects
    8. More...
  4. Forms
    1. Biosafety Forms
    2. Chemical Safety Forms
    3. Equipment Release Certification Form
    4. Fact Sheets
    5. Fire Safety Forms
    6. Hot Work Permit
    7. Laser Registration
    8. Material Safety Data Sheets
    9. Radiation Safety Forms
    10. Small Claims Incident Report Form
  5. Training
    1. Lab Safety Training
    2. Radiation Safety Training
    3. Right-to-Know Training

Home > Departments > Environment, Health & Safety > EH&S Programs > Biological Safety > Containment Categories

Containment Categories

Containment Categories for Commonly Used Agents/Cells


Cells and cell lines Guidelines adapted from ATCC recommendations; ATCC catalog

  • BL1: Cell lines which are of sub-primate or normal primate origin, which do not harbor a primate virus, and which are not contaminated by fungi, bacteria, mycoplasma, etc.
  • BL2: Primate cell lines derived from lymphoid or tumor tissues, all cell lines exposed to or transformed by a primate oncogenic virus, all clinical materials, all mycoplasma-contaminated cell lines should be handled at BL2 containment, whether or not they have been shown to contain a BL2 agent.
  • Other: Cell lines known to contain/produce an infectious etiologic agent or virus can be classified at the same level as that recommended for the etiologic agent or virus.

Infectious agents and vector systems 

  • BL1: recombinant DNA (generic K12 E. coli); murine retrovirus vectors; baculovirus; adeno-associated virus (AAV) and AAV vectors; herpesvirus saimiri; avian and murine retroviruses and vectors derived from these viruses.
  • BL2: moderately hazardous agents: adenovirus and adenovirus vectors; human herpesviruses 1 thru 7; human papillomaviruses; respiratory syncytial virus; poliovirus; influenza virus; enterotoxic E. coli; Neisseria; Staph and Strep; Mycoplasma; vaccinia virus and recombinant vaccinia virus vectors. Specific instructions on vaccinia virus vectors/recombinant vaccinia virus are available (see below).
  • BL2+: more hazardous agents under controlled/small scale conditions: lab scale HIV; lab scale HTLV; lab scale SIV; small scale work with Rickettsia spp.; SFV vectors (from Life Technologies: SFV is RG3, but this system was specifically approved at BL2); Note: See serum banking policy (this applies to BL2+ or higher organisms)
  • BL3: more hazardous agents, to be used in the MRB only: Mycobacterium tuberculosis; large-scale work with Rickettsia spp.; Note: See serum banking policy (this applies to BL2+ or higher organisms)
  • Other: If the organism/agent of interest is not listed, ask. Also, please consult with staff re. HIV vector systems.

NOTE: Consult the online NIH Guidelines for more complete and up-to-date information on containment issues. The above listings are for informational purposes only.